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Iridium(III) Complex-based Activatable Probe for 
Phosphorescent/Time-gated Luminescent Sensing and Imaging 
of Cysteine in Mitochondria of Live Cells and Animals 
Zhongbo Du,[a] Run Zhang,*[b] Bo Song,[a] Wenzhu Zhang,*[a]  Yong-Lei Wang,[c] Jianping Liu,[b]  
Chaolong Liu,[a] Zhi Ping Xu,[b] and Jingli Yuan*[a] 
 
Abstract: This study reports an activatable iridium(III) complex probe 
for phosphorescence/time-gated luminescence detection of cysteine 
(Cys) in vitro and in vivo. The probe, [Ir(ppy)2(NTY-bpy)](PF6), is 
developed by incorporating a strong electron withdrawing group, 
nitroolefin, into a bipyridine ligand of the Ir(III) complex. The 
luminescence of the probe is quenched due to the intramolecular 
charge transfer (ICT) process, but switched on by a specific 
recognition reaction between the probe and Cys. [Ir(ppy)2(NTY-
bpy)](PF6) shows high sensitivity and selectivity for Cys detection and 
good biocompatibility. The long-lived emission of [Ir(ppy)2(NTY-
bpy)](PF6) allows time-gated luminescence analysis of Cys in cells 
and human sera. These properties make it convenient for the 
phosphorescence and time-gated luminescence imaging and flow 
cytometry analysis of Cys in live samples. The Cys images in cancer 
cells and inflamed macrophage cells reveal that [Ir(ppy)2(NTY-
bpy)](PF6) is distributed in mitochondria after cellular internalization. 
Visualizations and flow cytometry analysis of mitochondrial Cys levels 
and Cys-mediated redox activities of live cells are achieved. Using 
[Ir(ppy)2(NTY-bpy)](PF6) as a probe, in vivo sensing and imaging of 
Cys in D. magna, zebrafish, and mice are then demonstrated. 
Introduction 
Advanced biomedical diagnosis heavily relies on the 
determination and tracking of diseases-related biomarkers in vitro 
and in vivo, so that the diseases can be prevented at the early 
stage.[1] Biothiols, including cysteine (Cys), homocysteine (Hcy) 
and glutathione (GSH), have long been recognized as the most 
important biomarkers inside the body, where the levels of biothiols 
are implicated in several disorders, such as inflammation, 
cardiovascular diseases, and even cancers.[2] Typically, biothiols 
play essential roles in various physiological processes of 
biological systems.[3] For example, Cys and Hcy are the crucial 
biomolecules required for cellular growth in living organisms, and 
GSH is the most abundant biothiol to play a key role in redox 
homeostasis.[4] For Cys, deficiency of this amino acid inside the 
body is associated with many diseases, such as slow growth, hair 
depigmentation, edema, lethargy, liver damage, loss of muscle 
and fat, skin lesions, and weakness.[5] Abnormal level of Hcy is 
related to the disorders including cardiovascular disease and 
Alzheimer’s disease.[4b] Although GSH serves as an important 
biomolecule in maintaining the intracellular redox activities and 
signal transduction, alterations in its level are implicated with liver 
damage, HIV infection, cancer, leucocytes loss, and psoriasis.[6] 
Cells are the fundamental building block of all live organisms, 
and cellular organelles are the essential parts of the cell’s 
structure and function. In live cells, mitochondria are the critical 
mediators of redox homeostasis because of their roles in 
generation and dissipation of reactive oxygen/nitrogen species 
(ROS/RNS).[7] The mitochondrial Cys is likely to be the key harbor 
for oxidative and nitrosative modifications led by highly reactive 
ROS/RNS, and thus Cys serves as the crucial biomolecule in 
mitochondria to control the critical homeostasis processes such 
as apoptosis, oxidative phosphorylation and redox signaling.[8] 
Therefore, it is of great value to engineer effective bioanalytical 
methods for the detection of Cys, in particular for the sensing and 
imaging of Cys-mediated redox signaling in mitochondria of 
biological systems suffering the ROS/RNS stress.[9] 
Among various methods reported,[10] one of the most useful 
approaches would be the luminescence bioassay, where the 
luminescent molecular probes are developed for direct detection 
of biomarkers in biological milieus.[11] In consideration of main 
advantages of their sensitivity and selectivity, several 
fluorescence probes have been recently developed by 
conjugating biothiol-responsive units to fluorophores, such as 
rhodamine,[12] coumarin,[13] naphthalimide,[14] BODIPY,[15] and 
fluorescein.[16] Through a specific sensing mechanism, such as 
cyclization of aldehydes,[17] Michael addition reaction,[18] cleavage 
of sulfonamide and sulfonate esters,[19] and cleavage of S-S bond 
and Se-N bond,[20] the fluorescence signal can be modulated for 
quantification of biothiols. Nevertheless, the probes that can 
discriminate Cys from other amino acids in a specific organelle 
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are scarcely reported.[21] In this context, development of 
responsive phosphorescence probes for sensing and imaging of 
Cys at subcellular levels, in particular for detection of Cys-
mediated redox activities in mitochondria, is urgently demanded. 
In past several years, transition metal complex-based 
activatable phosphorescence probes that can be used for sensing 
and imaging of important biomarkers have been attracted 
considerable attention due to their unique photophysical, 
photochemical, and electrochemical properties.[22] Among these 
metal complexes, cyclometalated Ir(III) complexes are particularly 
intriguing due to their several favorable photophysical properties 
for luminescence bioassays:[23] i) tunable luminescence 
emissions with variations of coordinative ligands; ii) high stability 
under ambient conditions and bright luminescence emissions; iii) 
large Stokes shift; iv) resistance to photobleaching; v) low 
cytotoxicity; vi) long emission lifetime; and vii) cell organelle-
targetable feature.[24] In previous researches, we have also 
confirmed the capability of Ir(III) complex-based responsive 
phosphorescence probes for the detection of biomarkers, such as 
reactive oxygen species,[25] and methylglyoxal in vitro and in 
vivo.[26] These facts promote us to design a unique Ir(III) complex 
phosphorescence probe for highly sensitive detection of Cys, and 
for further studies of Cys-mediated redox activities in biological 
systems. 
In this contribution, a functional Ir(III)-phenylpyridine complex 
derivative [Ir(ppy)2(NTY-bpy)](PF6) [ppy: 2-phenylpyridine; NTY-
bpy: 4-methyl-4’-(2-nitrovinyl)-2,2’-bipyridine], is reported for the 
sensing and imaging of Cys in vitro and in vivo (Scheme 1). Due 
to a strong electron withdrawing group coupled to the 2,2’-
bipyridine ligand, the phosphorescence emission of 
[Ir(ppy)2(NTY-bpy)](PF6) is quenched by intramolecular charge 
transfer (ICT) process. In the presence of Cys, a specific 
recognition reaction between the complex and Cys occurs, which 
affords the product, [Ir(ppy)2(Cys-bpy)](PF6). With this specific 
reaction, remarkable “OFF-ON” phosphorescence response 
could be obtained for Cys detection. The recognition reaction 
between [Ir(ppy)2(Cys-bpy)](PF6) and Cys was confirmed by 
HRMS analysis and Griess test. The “OFF-ON” phosphorescence 
response was rationalized by DFT/TD-DFT computations. The 
data of spectrometric titration analysis reveals that [Ir(ppy)2(NTY-
bpy)](PF6) can sensitively respond to Cys over other amino acids. 
[Ir(ppy)2(NTY-bpy)](PF6) features low cytotoxicity and cell 
membrane permeability, which enables it suitable as a probe for 
detection of Cys in living biological samples. [Ir(ppy)2(NTY-
bpy)](PF6) and [Ir(ppy)2(Cys-bpy)](PF6) exhibited long emission 
lifetimes, facilitating the time-gated luminescence analysis of Cys 
in human sera and visualization of Cys in live cells.[27] 
Luminescent imaging and flow cytometry analysis of Cys in 
mitochondria of live cells as well as luminescent imaging of Cys 
in D. magna, zebrafish, and mouse were then performed. In 
particular, the visualization of Cys-mediated redox in 
inflammatory mimic macrophage cells was achieved, which 
suggests that [Ir(ppy)2(NTY-bpy)](PF6) could be a promising 
probe for further biomedical applications in early diagnosis and 
treatment monitoring of inflammation diseases. 
 
Scheme 1. Schematic illustration of the luminescence response mechanism of 
[Ir(ppy)2(NTY-bpy)](PF6) towards Cys (A) and the application of [Ir(ppy)2(NTY-
bpy)](PF6) for phosphorescence and time-gated luminescence analysis of Cys-
mediated mitochondria redox activity, Cys in D. magna, zebrafishand mouse, 
and Cys in human blood sera. 
Results and Discussion 
Design, synthesis and characterization of the iridium(III) 
complex probe 
 
Transition metal complex-based luminescent probes have 
provided an alternative approach for the analysis of biomolecules 
in vitro and in vivo.[22i, 28] Among phosphorescence probes, 
phosphorescent Ir(III) complexes contribute significantly to the 
development of activatable probes for bioassay and bioimaging 
due to their abundant photochemical, photophysical, and 
electrochemical properties.[29] Considering the important roles of 
Cys in biological systems and the unique properties of Ir(III) 
complexes, we developed Ir(III) complex-based responsive 
probes for phosphorescence and time-gated luminescence 
detection of Cys in aqueous and live organisms. 
An Ir(III) complex-based probe, [Ir(ppy)2(NTY-bpy)]+, was 
designed by coupling a nitroolefin moiety to the bipyridine ligand 
for specifically responding to Cys. In the presence of Cys, this 
nitroolefin moiety can react with the mercapto group of Cys 
through a 1,4-addition reaction,[30] followed by the removal of nitro 
group to form the product [Ir(ppy)2(Cys-bpy)]+ (Scheme 1). Due 
to the incorporation of strong electron withdrawing nitroolefin 
moiety into the Ir(III) complex, the emission of [Ir(ppy)2(NTY-
bpy)]+ is expected to be quenched by the ICT process. While the 
luminescence can be switched-on by the corruption of ICT 
process after removal of nitro group. More importantly, 
considering the intrinsic cationic lipophilicity of the Ir(III) complex, 
[Ir(ppy)2(NTY-bpy)]+ is anticipated to be accumulated in 
mitochondria after cellular uptake, thereby the subcellular 
concentration level of Cys can be visualized. 
The NTY-bpy ligand was firstly synthesized by the reaction of 
CHO-bpy with nitromethane in anhydrous toluene (Scheme S1, 
Supporting Information). This ligand was then subjected to a 
coordination reaction with [Ir2(ppy)4Cl2] in MeOH-CH2Cl2 to yield 
the corresponding Ir(III) complex, [Ir(ppy)2(NTY-bpy)](PF6). The 
chemical structure of the ligand NTY-bpy and [Ir(ppy)2(NTY-
bpy)](PF6) was confirmed by NMR, ESI-MS, HRMS, and 
elemental analysis (Figures S1-S5, Supporting Information). 
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The product of [Ir(ppy)2(NTY-bpy)]+ reacting with Cys was 
further investigated by ESI-MS analysis. Upon addition of Cys into 
[Ir(ppy)2(NTY-bpy)]+ solution, the peak at m/z = 816.25 was 
observed, which can be assigned to [Ir(ppy)2(Cys-bpy)]+ (Figure 
S6, Supporting Information). The result of HRMS showed the 
peak at m/z = 816.1969 (Figure S7, Supporting Information), 
which can also be ascribed to [Ir(ppy)2(Cys-bpy)]+ (calcd. m/z = 
816.1961). To confirm the removal of the nitrite ion, Griess 
reagent was added to the reaction solution of [Ir(ppy)2(NTY-
bpy)]+ and Cys, and the UV-vis spectra were measured. The 
absorption spectra of [Ir(ppy)2(NTY-bpy)]+ and Griess reagent 
were measured as the controls. Intense absorption band at 450-
600 nm was observed, indicating the release of nitrite after the 
reaction (Figure S8, Supporting Information).  
 
Photophysical properties of the iridium(III) complex probe 
 
The photophysical properties of [Ir(ppy)2(NTY-bpy)]+ and its 
reaction product with Cys, [Ir(ppy)2(Cys-bpy)]+, were then 
investigated. In the absence and presence of Cys, UV-vis 
absorption spectra of [Ir(ppy)2(NTY-bpy)]+ were firstly measured. 
As shown in Figure 1A, for all the UV-vis spectra, the strong 
absorption bands at around 280-320 nm could be assigned to the 
spin-allowed intraligand charge transitions (1ILCT) of ligands ppy 
and NTY-bpy. Moderate intense absorption bands in the visible 
region were also observed, which can be ascribed to the overlap 
of the spin-allowed metal-to-ligand charge transfer (1MLCT), 
ligand-to-ligand charge transfer (1LLCT), and the 1ILCT. In the 
presence of Cys, decrease of the absorption band centered at 380 
nm was noticed, which might be caused by the corruption of 1ILCT 
transition after the reaction of [Ir(ppy)2(NTY-bpy)]+ with Cys. 
As shown in Figure 1B, under excitation at 380 nm, 
[Ir(ppy)2(NTY-bpy)]+ displayed very weak phosphorescence, 
ascribed to the effective quenching induced by ICT from Ir(III) 
center to nitroolefin moiety. As expected, intense 
phosphorescence at 590 nm was emitted after the reaction of 
[Ir(ppy)2(NTY-bpy)]+ with Cys. This result indicates that the 
phosphorescence of [Ir(ppy)2(NTY-bpy)]+ can be switched-on in 
the presence of Cys owing to the production of [Ir(ppy)2(Cys-
bpy)]+ (quantum yield,  = 4.36%, Table S1, Supporting 
Information). 
Both [Ir(ppy)2(NTY-bpy)](PF6) and [Ir(ppy)2(Cys-bpy)](PF6) 
feature a large Stokes shift (> 200 nm), with absorption peaks at 
380 nm and emission peaks at 600 nm and 590 nm, respectively. 
The emission lifetime of [Ir(ppy)2(NTY-bpy)](PF6) and 
[Ir(ppy)2(Cys-bpy)](PF6) were determined to be 86 ns (Figure S9, 
Supporting Information) and 103 ns (Figure S10, Supporting 
Information), respectively. The long emission lifetime enables the 
assay of Cys to be performed in a background free time-gated 
luminescence mode. 
 
Theoretical calculation 
 
To deepen the discussion about the electronic structure, electron 
transfer, and photophysical properties of [Ir(ppy)2(NTY-bpy)]+ 
before and after reaction with Cys, specific investigations on the 
theoretical level, i. e., density functional theory (DFT) and time-
dependent DFT (TD-DFT) computations, were performed to 
evaluate the corresponding transition energies of [Ir(ppy)2(NTY-
bpy)]+ and [Ir(ppy)2(Cys-bpy)]+. The ground-state (S0) and 
excited state (T1) geometries of [Ir(ppy)2(NTY-bpy)]+ and 
[Ir(ppy)2(Cys-bpy)]+ were optimized taking into account effects of 
bulk solvent (H2O) by means of the polarizable continuum model 
(PCM). By DFT calculation, the molecular geometries of 
[Ir(ppy)2(NTY-bpy)]+ and [Ir(ppy)2(Cys-bpy)]+ were obtained as 
displayed in Figures S11, S12 (Supporting Information). The 
corresponding optimized geometrical parameters in S0 and T1 
states are shown in Table S2, S3 (Supporting Information). 
 
Figure 1. (A) UV-vis absorption spectra of [Ir(ppy)2(NTY-bpy)]+ (20 μM) and 
(B) phosphorescence spectra of [Ir(ppy)2(NTY-bpy)]+ (10 μM) in the absence 
and presence of Cys (20 μM). ex = 380 nm, em = 590 nm. (C) Frontier molecular 
orbital distributions (HOMO and LUMO) of [Ir(ppy)2(NTY-bpy)]+ and 
[Ir(ppy)2(Cys-bpy)]+ at their optimized geometries of lowest triplet excited 
states (T1). The energy levels of the MOs are shown. 
     Optimized molecular geometries clearly exhibit the -
conjugation extended to C=C double bond for both [Ir(ppy)2(NTY-
bpy)]+ (Figure S11, Supporting Information) and [Ir(ppy)2(Cys-
bpy)]+ (Figure S12, Supporting Information). Based on the 
optimized ground state molecular geometries, the highest 
occupied molecular orbital (HOMO), lowest unoccupied molecular 
orbital (LUMO), and nearby molecular orbitals were calculated 
(Figures S13, S14, Supporting Information). For [Ir(ppy)2(NTY-
bpy)]+, orbital analyses show that the HOMOs are mainly located 
on the Ir(III) centre and ppy ligands, with small distribution on the 
4-methylpyridine of NTY-bpy ligand in HOMO-2. LUMOs of 
[Ir(ppy)2(NTY-bpy)]+ are distributed on the NTY-bpy ligand. 
Interestingly, LUMO of [Ir(ppy)2(NTY-bpy)]+ clearly shows major 
contribution from the 4-(2-nitrovinyl)pyridine, rather than the 
whole bipyridine moiety. 
Based on the optimized ground state molecular geometries of 
[Ir(ppy)2(NTY-bpy)]+ and [Ir(ppy)2(Cys-bpy)]+, TD-DFT 
calculations were carried out to explore the electronic transitions 
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corresponding to their absorption profiles. As shown in Table S4 
(Supporting Information), the electronic transition from the ground 
state to the first excited singlet state (S1) is mainly contributed by 
HOMO→LUMO, which could be assigned to 1MLCT and 1LL’CT 
characters (L: ppy; L’: NTY-bpy or Cys-bpy). These 1MLCT, 
1LL’CT, and 1L’LCT transitions were noticed in all excited singlet 
states (S1-S7) of both [Ir(ppy)2(NTY-bpy)]+ and [Ir(ppy)2(Cys-
bpy)]+. 
To further examine the phosphorescence “OFF-ON” response, 
TD-DFT calculations were performed to understand the emission 
electronic transitions at the lowest-lying triplet excited state 
optimized molecular geometries of [Ir(ppy)2(NTY-bpy)]+ and 
[Ir(ppy)2(Cys-bpy)]+. The emission electronic transitions (T1-T8) 
of [Ir(ppy)2(NTY-bpy)]+ and [Ir(ppy)2(Cys-bpy)]+) are exhibited 
in Table S5 (Supporting Information), and the representative 
frontier molecular orbital distributions of [Ir(ppy)2(NTY-bpy)]+ and 
[Ir(ppy)2(Cys-bpy)]+ are presented in Figures S15, S16 
(Supporting Information). The molecular orbital distributions of 
[Ir(ppy)2(NTY-bpy)]+ and [Ir(ppy)2(Cys-bpy)]+ in triplet states 
were noticed to be similar to that of molecular orbital distributions 
in S0 states. In [Ir(ppy)2(NTY-bpy)]+, 1T is mainly involved 
(95.8%) in the HOMO→LUMO transition (Table S5, Supporting 
Information). As shown in Figure 1C, this transition can be 
attributed to the 3MLCT and 3LL’CT characters. Charge transfer 
to NTY moiety was clearly noticed from the HOMO→LUMO 
transition of [Ir(ppy)2(NTY-bpy)]+. As the result, the 
luminescence of [Ir(ppy)2(NTY-bpy)]+ is quenched. In 
[Ir(ppy)2(Cys-bpy)]+, T1 is mainly contributed by the transition 
from HOMO→LUMO (57.1%) with small contribution from 
HOMO-2→LUMO (13.1%) and HOMO-1→LUMO (12.3%) 
transitions. These transitions exhibit obvious 3MLCT and 3LL’CT 
characters. The emissive transitions, including 3MLCT, 3L’LCT 
and 3L’LCT of T1 and other triplet excited states, are consistent 
with the typical photophysical properties of iridium(III) complexes. 
Therefore, the phosphorescence emission is switched-on when 
[Ir(ppy)2(NTY-bpy)]+ is transferred to [Ir(ppy)2(Cys-bpy)]+ in the 
presence of Cys. 
 
Phosphorescence turn-on response of [Ir(ppy)2(NTY-
bpy)](PF6) to Cys 
 
Emission spectrum response of [Ir(ppy)2(NTY-bpy)]+ towards 
different concentrations of Cys was firstly investigated after 
incubation of [Ir(ppy)2(NTY-bpy)]+ and Cys for 30 min. As shown 
in Figure 2A, the emission intensity was gradually increased with 
increasing the Cys concentration. The dose-dependent emission 
enhancement exhibited a good linearity in the concentration 
range of 0-10.0 M (Figure S17, Supporting Information). The 
detection limit was calculated to be 86 nM based on the reported 
methods defined by IUPAC. These data indicate that 
[Ir(ppy)2(NTY-bpy)]+ can be used for highly sensitive 
phosphorescence detection of Cys. 
To confirm the phosphorescence response specificity of the 
probe to Cys, the phosphorescence intensity of [Ir(ppy)2(NTY-
bpy)]+ after reaction with various amino acids was recorded. As 
shown in Figure 2B, upon reaction with 10 M of Cys, the 
phosphorescence intensity was remarkably increased, while 
negligible luminescence increases were noticed even though 
[Ir(ppy)2(NTY-bpy)]+ was reacted with 500 M of other amino 
acids. These results demonstrate high specificity of the 
phosphorescence response of [Ir(ppy)2(NTY-bpy)]+ towards Cys. 
 
Figure 2. (A) Emission spectra of [Ir(ppy)2(NTY-bpy)]+ (10 M) reacted with 
different concentrations of Cys (0-10 M). (B) Phosphorescence intensities of 
[Ir(ppy)2(NTY-bpy)]+ (10 M) reacted with various amino acids. (a) Blank, (b) 
Cys, (c) GSH, (d) Hcy, (e) Trp, (f) Thr, (g) Gly, (h) Val, (i) Leu, (j) His, (k) Pro, (l) 
Ser, (m) Tyr, (n) Ala, (o) Asp, (p) Arg, ,(q) human serum albumin (HSA, 100 M). 
(C) Time-profile phosphorescence response and (D) pH effect on the 
phosphorescence response of [Ir(ppy)2(NTY-bpy)]+ (10 μM) (black line) 
towards biothiols (10 μM for Cys, red line; 20 μM for Hcy, blue line; and 20 μM 
for GSH, green line) in CH3CN-PBS buffer (25 mM, pH 7.4, 1/1, v/v). ex= 380 
nm, em= 590 nm. 
As the simialr chemical structure of Cys, Hcy, and GSH, small 
enhancement in phosphorescnece intensity was also noticed 
upon the addition of Hcy and GSH (10 M). To confirm the 
selectivity of [Ir(ppy)2(NTY-bpy)]+ towards Cys over other 
biothiols, time-dependent phosphorescence responses of 
[Ir(ppy)2(NTY-bpy)]+ towards Cys, Hcy and GSH were 
investigated by recording the changes of the emission intensity at 
590 nm. As shown in Figure 2C, [Ir(ppy)2(NTY-bpy)]+ solution 
exhibited weak and stable emission under continuous excitation 
at 380 nm. After adding Cys, the phosphorescence intensity was 
gradually increased, and reached a maximum value at ~30 min, 
indicating that the reaction between [Ir(ppy)2(NTY-bpy)]+ and 
Cys was completed within 0.5 h. For Hcy and GSH, slight 
enhancement in the luminescence intensity was observed after 
incubation for up to 2 h (Figure S18, Supporting Information), 
which indicates that [Ir(ppy)2(NTY-bpy)]+ has the potential to 
distinguish Cys from Hcy and GSH. 
The effects of pH on the phosphorescence responses of 
[Ir(ppy)2(NTY-bpy)]+ towards Cys, Hcy and GSH were further 
examined by recording the phosphorescence intensity changes at 
590 nm in the absence and presence of three biothiols. As shown 
in Figure 2D, the phosphorescence intensity of [Ir(ppy)2(NTY-
bpy)]+ was found to be weak and stable in PBS buffers with 
different pH values ranged from 4.0 to 10.0. Upon reaction with 
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Cys, the phosphorescence intensity was gradually increased in 
the range of pH 4.5-7.5, and the maximum phosphorescence 
intensity was obtained at pH 7.5. In contrast, no obvious 
phosphorescence enhancement was observed after probe 
solution reacted with GSH. Increasing pH (>7) enhanced the 
phosphorescence intensity of [Ir(ppy)2(NTY-bpy)]+-Hcy solution 
slightly. Phosphorescence response of [Ir(ppy)2(NTY-bpy)]+ 
towards Hcy in alkaline solution could be attributed to the higher 
pKa value of Hcy (pKa = 10.0).[31] Together with the slow 
responses of [Ir(ppy)2(NTY-bpy)]+ towards Hcy and GSH (Figure 
2C), the high reactivity of [Ir(ppy)2(NTY-bpy)]+ with Cys may be 
attributed to the high nucleophilicity of its -SH group in biological 
pH level (pKa of Cys is 8.53, compared with 10.0 of Hcy and 9.20 
of GSH) and its weak steric effect.[21b, 31] 
 
Time-gated luminescence analysis of Cys 
 
Thanks to the long emission lifetime of [Ir(ppy)2(NTY-bpy)]+ and 
[Ir(ppy)2(Cys-bpy)]+, time-gated luminescence analysis of Cys 
was performed in PBS buffer using LysoSensorTM Green (30 M) 
as the artificial background interference. As shown in Figure S19A 
(Supporting Information), only fast emission decay process of 
LysoSensorTM Green was noticed without Cys added. By contrast, 
both fast and slow emission decay processes were observed after 
the addition of Cys (Figure S19C, Supporting Information). This 
slow emission decay can be attributed to the long-lived emission 
of [Ir(ppy)2(Cys-bpy)]+. With the excitation at 405 nm, this probe 
solution exhibited intense green emission, and such an emission 
spectrum was not changed in the presence of Cys (Figure S19B, 
Supporting Information). However, the background green 
emission was effectively removed by time-gated analysis with a 
50 ns delay. Significant enhancement in luminescence at 590 nm 
was observed after reaction with Cys (Figure S19D, Supporting 
Information). These data suggests the potential of [Ir(ppy)2(NTY-
bpy)]+ for the background-free time-gated luminescence detection 
of Cys. 
Thus, time-gated luminescence response of [Ir(ppy)2(NTY-
bpy)]+ towards different concentrations of Cys was examined by 
the titration. As shown in Figure 3A, time-gated luminescence 
intensity of [Ir(ppy)2(NTY-bpy)]+ was gradually increased after 
reaction with the increasing Cys concentration, and the intensity 
showed a good linearity with the Cys concentration in the range 
of 0-10 M (Figure 3B), which indicates that the Cys level can be 
quantified by time-gated luminescence analysis. 
On the basis of these data, the concentration level of Cys in 
human sera was determined with the time-gated luminescence 
method. The sera were collected from healthy volunteers, and 
then 100-fold diluted with PBS buffer before the addition of 
[Ir(ppy)2(NTY-bpy)]+. As shown in Figure 3C, weak 
autofluorescence from serum samples was noticed even after 
100-fold dilution, while such a background signal was effectively 
removed using time-gated mode (Figure 3D). Upon mixing with 
100-times diluted human sera for 0.5 h, phosphorescence and 
time-gated luminescence was 6.4-fold and 9.1-fold enhanced, 
respectively. Further enhancements in both phosphorescence 
and time-gated luminescence were observed in the presence of 
Cys. Using the standard curve shown in Figure 3B, the 
concentration of Cys in human sera was determined to be 254 ± 
16 M, which is consistent with the reported.[15d] By adding 
exogenous Cys into the diluted human sera, the recovery of 
added Cys was determined to be 89.8-90.5% (Table S6, 
Supporting Information), indicating that the time-gated 
luminescence analysis of Cys using [Ir(ppy)2(NTY-bpy)]+ as a 
probe is highly accurate. 
 
Figure 3. (A) Time-gated luminescence spectra of [Ir(ppy)2(NTY-bpy)]+ (10 
M) in the presence of different concentration of Cys; (B)  standard curve for 
the time-gated luminescence detection of Cys; (C) phosphorescence and (D) 
time-gated luminescence analysis of Cys in human serum samples with 
[Ir(ppy)2(NTY-bpy)]+ (10 M) as a probe (exogenous Cys addition: 5 M).. 
Imaging of Cys in live cells 
 
Prior to the imaging application, the cytotoxicity of [Ir(ppy)2(NTY-
bpy)]+ towards MCF-7 cells and J774A.1 macrophage cells was 
evaluated by MTT assay and PrestoBuleTM viability assay, 
respectively. Upon incubating MCF-7 cells with [Ir(ppy)2(NTY-
bpy)]+ at the concentrations of 0, 10, 20, 40, 100, and 200 M, 
remarkable effects on the cell proliferation were not observed 
(Figure S20, Supporting Information). The cell viability remained 
at over 67% even after co-incubating MCF-7 cells with 200 M 
[Ir(ppy)2(NTY-bpy)]+ for 24 h. Then, the cytotoxicity of 
[Ir(ppy)2(NTY-bpy)]+ towards J774A.1 macrophage cells was 
assessed by PrestoBlueTM cell viability assay. The data showed 
that the cell viability remained to be about 84% after J774A.1 cells 
were incubation with 200 M of [Ir(ppy)2(NTY-bpy)]+ for 24 h. The 
results indicate that the cytotoxicity of [Ir(ppy)2(NTY-bpy)]+ is 
very limited.  Because a very low concentration of the complex 
(10-30 M) is normally used for the cell imaging, the cytotoxicity 
at these concentrations is negligible. 
To determine the time profile of the intracellular luminescence 
intensity, MCF-7 cells were incubated with 10 M [Ir(ppy)2(NTY-
bpy)]+ for different times (0.5, 1, 2, 3, 5 h), and then the MFI was 
measured by flow cytometry. As shown in Figure S21 (Supporting 
Information), significant enhancement of MFI was observed for 
MCF-7 cells incubated with [Ir(ppy)2(NTY-bpy)]+ within 2 h. After 
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2 h, increase of mean luminescence intensity (MFI) became 
rather slow. This result suggests that the imaging of Cys in live 
cells could be performed within 1-2 h co-incubation.  
As shown in Figure S22 (Supporting Information), clear red 
luminescence was observed after MCF-7 cells were incubated 
with 10 M of [Ir(ppy)2(NTY-bpy)]+ for 2 h. To confirm the 
intracellular luminescence was indeed originated from the 
reaction product of [Ir(ppy)2(NTY-bpy)]+ with Cys, MCF-7 cells 
were pretreated with 500 M NEM (N-ethylmaleimide) for 1 h, 
followed by the incubation with [Ir(ppy)2(NTY-bpy)]+ for 2 h. In 
this case, the cells showed weak luminescence as the biothiols 
were scavenged by NEM (Figure S22B, Supporting Information). 
In another group, after NEM treatment and [Ir(ppy)2(NTY-bpy)]+ 
incubation, the cells were supplied with 200 M of Cys for another 
1 h. Significant luminescence was observed again (Figure S22C, 
Supporting Information). To quantify the changes of intracellular 
luminescence in different conditions, flow cytometry analysis was 
performed to record the luminescence intensity of each cell 
population of MCF-7 cells. The MFI of the [Ir(ppy)2(NTY-bpy)]+-
loaded cells was significantly decreased when the intracellular 
Cys was scavenged by NEM, while the further incubation with Cys 
recovered the intracellular luminescence intensity (Figure S23, 
Supporting Information). 
The intracellular images also shows that the red luminescence 
signals were not even in the cytoplasm. This observation implies 
the subcellular localization of the luminescent products of 
[Ir(ppy)2(NTY-bpy)]+ reacted with Cys in MCF-7 cells. 
Considering the character of mitochondria accumulation of 
cationic Ir(III) complexes,[32] the [Ir(ppy)2(NTY-bpy)]+-loaded 
MCF-7 cells were then incubated with MitoTrackerTM Green FM to 
confirm its mitochondria distribution after cellular uptake. Clear 
yellow luminescence (overlap of red luminescence from the 
product of [Ir(ppy)2(NTY-bpy)]+ reacted with Cys and green 
fluorescence from MitoTrackerTM Green FM) in MCF-7 cells was 
observed (Figure S24, Supporting Information). The intensity 
profile of linear regions of interests across MCF-7 cells (ROIs 1 
and 2) shows obviously synchronous luminescence signals, 
suggesting the co-localization of [Ir(ppy)2(NTY-bpy)]+ and 
MitoTrackerTM Green FM in MCF-7 cells. The Pearson’s 
correlation coefficients and the Mander’s overlap coefficients 
were determined to be 0.852 and 0.867, respectively. Both 
coefficients are close to 1 in the colocalization analysis, indicating 
that the majority of [Ir(ppy)2(NTY-bpy)]+ localized within 
mitochondria of MCF-7 cells. This localization feature shows that 
the Cys levels in mitochondria of live cells can be visualized by 
using [Ir(ppy)2(NTY-bpy)]+ as a probe. 
Considering the importance of photostability of the 
luminescence probes for optical analysis and imaging, the 
resistance to photobleaching of [Ir(ppy)2(NTY-bpy)]+ and 
[Ir(ppy)2(Cys-bpy)]+ was examined in buffer solution and live 
cells. As shown in Figure S25 (Supporting Information), no 
obvious changes of the phosphorescence intensity were noticed 
for [Ir(ppy)2(NTY-bpy)]+ and [Ir(ppy)2(Cys-bpy)]+ solutions after 
UV irradiation for 2 h. The stability was then confirmed by imaging, 
where the cell images were recorded for 10 times at 100% laser 
power. As shown in Figure S26 (Supporting Information), no 
changes of intracellular signals were observed after scanning for 
10 times, indicating the high stability of the Ir(III) complexes to 
resist the photobleaching. 
Using [Ir(ppy)2(NTY-bpy)]+ as a probe, we then demonstrated 
the time-gated luminescence imaging of Cys in live MCF-7 cells. 
MCF-7 cells were incubated with [Ir(ppy)2(NTY-bpy)]+, followed 
by staining with LysoSensorTM Green (the artificial noise signal) 
and Hoechst 33342 (staining for nuclei). As shown in Figure 4A-
D, blue channel stained with Hoechst 33342 showed consistent 
fluorescence without time-gating. Under pulsed laser excitation 
(470 nm), intense intracellular green and red emissions were 
observed for the signals recorded within 0-12 ns (Figure 4A). With 
time-gating at 0-6 ns (Figure 4B), intracellular emission intensity 
was decreased to 68.8 ± 10.7% (green channel) and 61.1 ± 4.6% 
(red channel), compared to control group shown in Figure 4A. 
While with the imaging time delayed for 6 and 8 ns, the emission 
of green channel decreased dramatically, to 29.9 ± 3.1% and 16.1 
± 4.2%, which is in contrast with the emission of red channel 
(>40%, Figure 4E). From 3D surface interactive intensity analysis 
of images shown in Figure 4A, B, the intensity of green channel 
was higher than that of red channel. However, with time delayed 
for 6 and 8 ns, the intracellular green emission was remarkably 
weakened, while the red emission was nearly the same (Figure 
4C, D). This is consistent with the increased signal to noise (S/N) 
ratio (Figure 4F), highlighting the advantages of time-gated 
luminescence cell imaging. 
  
Figure 4. Time-gated luminescence imaging of Cys in MCF-7 cells. MCF-7 cells 
were incubated with [Ir(ppy)2(NTY-bpy)]+ (10 M) for 2 h, followed by staining 
with Hoechst 33342 and LysoSensorTM Green. The signal from red and green 
channel were collected within 0-12 ns (A); 0-6 ns (B); 6-12 ns (C); and 8-12 ns 
(D). (E) Changes of intracellular red and green signal of group A-D; (F) signal 
to noise ratio of the images of group A-D. Scale bar, 10 m. 
It is known that high levels of reactive oxygen species (ROS) 
can be generated during the inflammatory response of 
macrophage cells. In a previous research, we have demonstrated 
the formation of H2S at a higher concentration level in J774A.1 
inflamed macrophage cells.45 As one of the most important 
antioxidants and the substrate for generating H2S, Cys is 
envisaged to be decreased in its concentration during the 
inflammation of macrophage cells. To investigate the Cys level 
changes in this process, J774A.1 macrophage cells were treated 
with 5.0 ng/mL lipopolysaccharide (LPS) for 2 h, followed by 
incubation with [Ir(ppy)2(NTY-bpy)]+ for another 2 h. As shown in 
Figure 5B, nearly no luminescence of live J774A.1 cells was 
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observed, obviously different from that in control group cells 
(Figure 5A, incubated with 10 M [Ir(ppy)2(NTY-bpy)]+ only for 2 
h). Then, the cells were supplied with 200 M of Cys for 1 h. Bright 
red luminescence signals from the cells were noticed (Figure 5C). 
The luminescence intensity is almost the same as that of the 
group where J774A.1 cells were supplied with 200 M Cys for 1 
h before staining with [Ir(ppy)2(NTY-bpy)]+ (Figure 5D). 
Similar to the distribution of [Ir(ppy)2(NTY-bpy)]+ in 
mitochondria of MCF-7 cells, the localization of [Ir(ppy)2(NTY-
bpy)]+ in this organelle in live J774A.1 cells was also noticed. The 
images with obviously overlapped yellow luminescence were 
obtained for the J774A.1 cells stained with both [Ir(ppy)2(NTY-
bpy)]+ and MitoTrackerTM Green FM (Figure 5E-J). The 
mitochondria localization was supported by the synchronous 
luminescence signals in the linear region of interest (ROIs 1 and 
2) across the cells (Figure 5K-L). Both Pearson’s correlation 
coefficients (0.895) and Mander’s overlap coefficients (0.904) are 
close to 1, revealing that the majority of [Ir(ppy)2(NTY-bpy)]+-
loaded vesicles localized within mitochondria of J774A.1 cells. 
The intensity correlation quotient (ICQ) for two stains was 
confirmed to be 0.426, which is close to 0.5, indicating that the 
stains of [Ir(ppy)2(NTY-bpy)]+ and MitoTrackerTM Green FM were 
dependent. 
 
Figure 5. (A-D) Luminescence imaging and 3D surface interactive intensity 
analysis of Cys in inflamed J774A.1 macrophage cells. (A) J774A.1 
macrophage cells were incubated with [Ir(ppy)2(NTY-bpy)]+ (10 M) for 2 h; (B) 
J774A.1 cells were treated with LPS (5.0 ng/mL) for 1 h, and then stained with 
[Ir(ppy)2(NTY-bpy)]+ (10 M) for 2 h; (C) the group B cells were further supplied 
with Cys (200 M) for another 1 h; (D) J774A.1 macrophage cells were treated 
with Cys (200 M) for 1 h, and then incubated with [Ir(ppy)2(NTY-bpy)]+ (10 
M) for another 2 h. (E-L) Intracellular colocalization luminescence imaging of 
J774A.1 cells. The cells were incubated with [Ir(ppy)2(NTY-bpy)]+ (10 M) for 
2 h, followed by staining with MitoTrackerTM Green FM and Hoechst 33342. (E) 
Merged image of red and blue channels; (F) merged image of green and blue 
channels; (G) merged image of red and green channels; (H) merged image of 
red, blue and green channels; (I) the zoom-in image of the cell shown in the 
dashed box in H; (J) merged image of H and bright-field. (K, L) Luminescence 
intensity profiles of the regions of interests (ROIs) across J774A.1 macrophage 
cells (line 1 in G and line 2 in I). Scale bar, 10 m. 
The evolution of Cys levels in inflamed J774A.1 macrophage 
cells at large scale cell populations was further investigated, 
where the MFI was analysed by flow cytometry. As shown in 
Figure S27 (Supporting Information), the LPS-stimulated J774A.1 
macrophage cells showed only weak luminescence, while the MFI 
was significantly increased after supplying the inflamed cells with 
Cys. The luminescence intensity was found to be similar to that of 
the group where J774A.1 cells were treated with Cys directly 
before incubation with [Ir(ppy)2(NTY-bpy)]+, which is in 
agreement with the results obtained from luminescence imaging 
experiments. It has been well documented that LPS can stimulate 
the inflammation of macrophage cells. The above results 
demonstrate that the Cys level is decreased in inflammation 
disorders, and such a variation at subcellular levels can be 
monitored by both luminescence imaging and flow cytometry 
analysis using [Ir(ppy)2(NTY-bpy)]+ as a probe. 
 
In vivo luminescence imaging of Cys in live organisms 
 
Figure 6. Bright-field, luminescence, and merged images of Cys in larval 
zebrafish using [Ir(ppy)2(NTY-bpy)]+ as a probe. (A) Zebrafish were incubated 
with [Ir(ppy)2(NTY-bpy)]+ (25 M) for 1 h, (B) zebrafish were pretreated with 
NEM (100 M) for 1 h, and then incubated with [Ir(ppy)2(NTY-bpy)]+ (25M) 
for 1 h, (C) the group (B) zebrafish were further supplied with Cys (100 M) for 
another 1 h. Scale bar, 500 m. (D) Image of adult zebrafish; (E) zebrafish were 
incubated with 150 M [Ir(ppy)2(NTY-bpy)]+ for 20 min; (F) zebrafish were 
treated with 500 M NEM and then incubated with 150 M [Ir(ppy)2(NTY-bpy)]+ 
for 20 min. Mean luminescence intensities of three groups were recorded and 
presented in (G). 
Daphnia magna (D. magna) is a widely used laboratory animal as 
an indicator of aquatic ecosystem health and as a model animal 
in ecotoxicology. For evaluating the feasibility of [Ir(ppy)2(NTY-
bpy)]+ as a luminescent probe for imaging Cys in living organisms, 
D. magna was incubated with [Ir(ppy)2(NTY-bpy)]+ (30 M) for 1 
h at 25 °C, followed by the luminescence imaging on the 
microscope. As shown in Figure S28A-C (Supporting Information), 
[Ir(ppy)2(NTY-bpy)]+-loaded D. magna showed strong red 
luminescence signals mainly in the range of the esophagus, 
hindgut and midgut. In a control group, a D. magna was 
pretreated with 100 M NEM for 1 h, and then incubated with 
[Ir(ppy)2(NTY-bpy)]+ (30 M) for another 1 h. In this case, almost 
no red luminescence from D. magna could be observed as Cys 
was scavenged by NEM (Figure S28D-F, Supporting Information). 
10.1002/chem.201805079
Ac
ce
pt
ed
 M
an
us
cr
ip
t
Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
FULL PAPER    
 
 
 
 
 
These images suggest that [Ir(ppy)2(NTY-bpy)]+ could be taken 
up into the body of D. magna through feeding process, and then 
reacted with endogenous Cys in the digestive system to give 
strong red luminescence signals. 
Visualization of Cys in live larval zebrafish was then performed 
to evaluate the in vivo application of [Ir(ppy)2(NTY-bpy)]+. Before 
imaging, the 5-day old zebrafish were pretreated with 100 M 
NEM for 1 h, followed by the incubation with 25 M [Ir(ppy)2(NTY-
bpy)]+ for another 1 h. For comparison, the NEM-pretreated 
zebrafish were further supplied with 100 M Cys for 1 h. In a 
control group, the zebrafish were only incubated with 25 M 
[Ir(ppy)2(NTY-bpy)]+ for 1 h. The zebrafish were washed, and 
then subjected to the imaging. As shown in Figure 6, intense red 
luminescence signals were observed in intestine from the 
[Ir(ppy)2(NTY-bpy)]+-loaded fish (Figure 6A), while almost no 
luminescence was obtained for the NEM-pretreated fish (Figure 
6B). In contrast, the red luminescence was recovered after further 
treating the fish with Cys (Figure 6C). Followed by the above 
imaging, the visualisation of Cys in adult zebrafish was then 
performed. As shown in Figure 6D, adult zebrafish exhibited 
autofluorescence slightly (Figure 6D), and intense luminescence 
signals were observed after the fish were treated with 
[Ir(ppy)2(NTY-bpy)]+ (150 M) for 20 min (Figure 6E). For the 
NEM-pretreated fish, the red luminescence signals almost 
disappeared (Figure 6F). All of above results demonstrate the 
feasibility of [Ir(ppy)2(NTY-bpy)]+ for the visualisation of Cys in 
live zebrafish. 
 
Figure 7. Luminescence imaging of Cys in live mice using [Ir(ppy)2(NTY-bpy)]+ 
as a probe. For area 1, PBS was injected into this area for 30 min, followed by 
the administering of [Ir(ppy)2(NTY-bpy)]+ (150 M); for area 2, 1.0 mM NEM in 
PBS was injected into this area for 30 min, followed by the administering of 
[Ir(ppy)2(NTY-bpy)]+ (150 M). Mean luminescence intensities at each time-
interval (0, 5, 10, 15, 20, 30, 40, 60, 80 and 100 min) were recorded. 
    The capability of [Ir(ppy)2(NTY-bpy)]+ for visualization of Cys 
in nude mice was finally investigated. For group 1, the mice were 
subcutaneously injected with PBS for 30 min, followed by the 
administering of [Ir(ppy)2(NTY-bpy)]+ (150 M) in the same area 
(area 1). As the negative control, the mice in group 2 were 
subcutaneously injected with 1.0 mM NEM in PBS for 30 min, 
followed by the administering of [Ir(ppy)2(NTY-bpy)]+ at the same 
area (area 2). Images were recorded at various time points. As 
shown in Figure 7, the luminescence signals for both 
[Ir(ppy)2(NTY-bpy)]+ injection areas were gradually increased 
within 100 min, but the luminescence intensity in area 2 was 
clearly lower than that in area 1. These results indicate that the 
Cys levels in live mice can be monitored using [Ir(ppy)2(NTY-
bpy)]+ as a probe. 
 
Conclusions 
In conclusion, a unique Ir(III) complex, [Ir(ppy)2(NTY-bpy)](PF6), 
has been designed and synthesized as a luminescent probe for 
sensing and imaging of Cys in vitro and in vivo. [Ir(ppy)2(NTY-
bpy)]+ itself exhibits weak luminescence, but shows a remarkable 
luminescence enhancement upon reaction with Cys. The 
spectrometric characterization reveals high sensitivity and 
selectivity of the probe in response to Cys over other amino acids. 
The probe shows good biocompatibility, cell-membrane 
permeability, and mitochondria-targeting ability, which enables 
the imaging and flow cytometry analysis of Cys in mitochondria of 
cancer cells and macrophage cells. We have also found that the 
Cys concentration in inflamed macrophage cells was significantly 
decreased, and the intracellular Cys concentration could be 
elevated through supplying exogenous Cys directly. These 
findings demonstrate the potential of the probe for the monitoring 
of Cys-mediated mitochondria redox activities in inflammatory 
disorders. Using this probe, we demonstrated luminescence 
sensing and imaging of Cys levels in D. magna, zebrafish, and 
live mice, which provides a new approach for the detection of Cys 
in vivo. The successful development of this probe is anticipated to 
contribute to the future biological researches related to the 
inflammation disease of live organisms. 
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Activatable probe specific for Cys 
detection in mitochondria of inflamed 
live cells and organisms is developed 
based on a unique Ir(III) complex. The 
probe, [Ir(ppy)2(NTY-bpy)]+ is 
capable of phosphorescence/time-
gated luminescence analysis of Cys 
in buffer, human sera, and live cells. 
Visualisation of Cys-mediated redox 
activities in mitochondria of inflamed 
cells and Cys in D. magna, zebrafish, 
and mice are demonstrated. 
 
 
 
Zhongbo Du, Run Zhang,* Bo Song, 
Wenzhu Zhang,* Yong-Lei Wang, 
Jianping Liu, Chaolong Liu, Zhi Ping 
Xu, and Jingli Yuan* 
Page No. – Page No. 
Iridium(III) Complex-based 
Activatable Probe for 
Phosphorescent/Time-gated 
Luminescent Sensing and Imaging 
of Cysteine in Mitochondria of Live 
Cells and Animals  
 
  
 
 
   
 
 
10.1002/chem.201805079
Ac
ce
pt
ed
 M
an
us
cr
ip
t
Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
